| Followers | 187 |
| Posts | 15499 |
| Boards Moderated | 0 |
| Alias Born | 08/26/2010 |
Monday, July 17, 2023 7:40:23 AM
Placebo is baking soda
Recent BBIO News
- BridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4:30 pm ET • GlobeNewswire Inc. • 04/30/2026 11:30:00 AM
- BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White • GlobeNewswire Inc. • 04/28/2026 11:30:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/24/2026 08:26:28 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 08:25:54 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 08:25:16 PM
- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/22/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:30:36 PM
- Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54 • GlobeNewswire Inc. • 03/30/2026 07:30:00 PM
- BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9 • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:33:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:32:18 PM
- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/20/2026 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/13/2026 08:22:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:15:36 PM
- BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9 • GlobeNewswire Inc. • 03/11/2026 06:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/10/2026 08:02:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 09:17:48 PM
- BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference • GlobeNewswire Inc. • 03/04/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 09:04:13 PM
- BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates • GlobeNewswire Inc. • 02/24/2026 09:01:00 PM
- BridgeBio to Participate in March Investor Conferences • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 11:39:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 11:36:26 PM
